Cardium Therapeutics, Inc.
3611 Valley Centre Drive
Suite 525
San Diego
California
92130
United States
Tel: 858-436-1000
Fax: 858-436-1001
Website: http://www.cardiumthx.com/
237 articles about Cardium Therapeutics, Inc.
-
Cardium Therapeutics, Inc. Announces Review In Journal Of Cardiovascular Pharmacology Finds Gene Therapy For Subset Of Heart Disease Patients 'Highly Warranted'
8/13/2014
-
Cardium Therapeutics, Inc. Announces Positive Interim Phase 3 Clinical Data Showing Significant Efficacy Of Generx® Angiogenic Gene Therapy For Myocardial Ischemia Due To Coronary Artery Disease At The 2014 Biotechnology Industry Organization (BIO) Intern
6/24/2014
-
Cardium Therapeutics, Inc. To Announce Interim Results Of Generx Angiogenic Gene Therapy Phase 3 Clinical Study At The 2014 Biotechnology Industry Organization (BIO) International Convention
6/12/2014
-
Shanxi Taxus To Gain Control Of Cardium Therapeutics, Inc. With $5 Million Investment
3/9/2014
-
Cardium Therapeutics, Inc. Announces Strategic Focus On Advanced Regenerative Therapeutics Based On Generx Clinical Findings
1/27/2014
-
Cardium Therapeutics, Inc. Reports On Third Quarter 2013 Financial Results And Recent Business Developments
11/19/2013
-
Cardium Therapeutics, Inc. Announces Publication on Use of Excellagen for Managing Chronic Pressure Ulcers in Elderly Patients
11/8/2013
-
Cardium Therapeutics, Inc. Provides Update on Exchange Listing
10/8/2013
-
Unusual Trading Activity in Cardium Therapeutics, Inc. Common Stock
9/30/2013
-
Cardium Therapeutics, Inc.'s LifeAgain Launches First Life Insurance Program Developed for Men With Active Localized Prostate Cancer
9/16/2013
-
Cardium Therapeutics, Inc.'s LifeAgain Announces Commercialization Agreement With AgencyONE Based on Advanced Medical Data Analytics Platform Technology
8/26/2013
-
Cardium Therapeutics, Inc. Reports on Second Quarter 2013 Financial Results and Recent Business Developments
8/14/2013
-
Cardium Therapeutics, Inc. Reports on Potential Use of Excellagen to Repair Prenatally Diagnosed Birth Defects Using Mesenchymal Stem Cells
8/13/2013
-
Cardium Therapeutics, Inc. Announces Excellagen Distribution Agreement With Kasiak for Germany and Switzerland
8/7/2013
-
Cardium Therapeutics, Inc. Reports on New Excellagen-Based Stromal Cell Research for Wound Healing With Orbsen Therapeutics Under European FP7 REDDSTAR Diabetes Initiative
8/6/2013
-
Cardium Therapeutics, Inc. Announces New Excellagen FDA 510(k) Submission Based on Expanded Structural and Functional Properties
8/5/2013
-
Cardium Therapeutics, Inc. Reports on New Excellagen Distribution Agreement With AvKARE for Veterans Hospitals and Other Governmental Medical Facilities
8/1/2013
-
Cardium Therapeutics, Inc. Completes Preferred Stock Financing
7/22/2013
-
Cardium Therapeutics, Inc. Announces Reverse Stock Split
7/18/2013
-
Cardium Therapeutics, Inc. Announces Final Voting Results of Annual Meeting of Stockholders
7/3/2013